Revolution Medicines Inc

Research Revolution Medicines Inc (RVMD) on Bullrun: market cap USD 40.95B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRVMD
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 40.95B
• Financial periodFY2025
• Net income-USD 1.13B
• Free cash flow-USD 913.73M

Valuation Snapshot

latest market cap is USD 40.95B.

About Revolution Medicines Inc

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers.

Frequently asked questions

What is Revolution Medicines Inc's market cap?

Revolution Medicines Inc's market capitalization is USD 40.95B.

What does Revolution Medicines Inc do?

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.